Do altering in ornithine decarboxylase activity and gene expression contribute to antiproliferative properties of COX inhibitors?

British Journal of Cancer

Volumn 88, Issue 7, 2003, Pages 1143-1151

  Ostrowski, J ^a   Wocial, T ^a   Skurzak, H ^a   Bartnik, W ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Apoptosis; C fos; C myc; COX inhibitors; Egr 1; ODC; Proliferation

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; MYC PROTEIN; ORNITHINE DECARBOXYLASE; PROTEIN C FOS; TRANSCRIPTION FACTOR EGR 1;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEPATOMA CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; TIME;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; ASPIRIN; CELL DIVISION; CYCLOOXYGENASE INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATOCYTES; ORNITHINE DECARBOXYLASE; PYRAZOLES; RATS; RNA, MESSENGER; SULFONAMIDES; TUMOR CELLS, CULTURED;

EID: 0038030681     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600815     Document Type: Article

References (49)

1. Beejay U, Wolfe MM (1999) Cyclooxygenase 2 selective inhibitors: panacea or flash in the pain. Gastroenterology 117: 1002-1014
2. Bello-Fernandez C, Packham G, Cleveland JL (1993) The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc Natl Acad Sci USA 90: 7804-7808
3. Bennett A, Tacca MD, Stamford IF, Zebro T (1977) Prostaglandins from tumours of human large bowel. Br J Cancer 35: 881-884
4. Denkert C, Kobel M, Berger S, Siegert A, Leclere A, Trefzer U, Hauptmann S (2001) Expression of cyclooxygenase 2 in human malignant melanoma. Cancer Res 61: 303-308
5. Dermott JM, Reddy RMV, Onesime D, Reddy EP, Dhanasekaran N (1999) Oncogenic mutant of Gα12 stimulates cell proliferation through cyclooxygenase-2 signaling pathway. Oncogene 18: 7185-7189
6. Ding XZ, Tong WG, Adrian TE (2000) Blockade of cyclooxygenase-2 inhibitors proliferation and induces apoptosis in human pancreatic cancer cells. Anticancer Res 20: 2625-2631
7. Eberhart CE, DuBois RN (1995) Eicosanoids and the gastrointestinal tract. Gastroenterology 109: 285-301
8. Elder DJE, Halton DE, Crew TE, Parakseva C (2000) Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398. Int J Cancer 86: 553-560
9. Erickson BA, Longo WE, Panesar N, Mazuski JE, Kaminski DL (1999) The effect of selective cyclooxygenase inhibitor on intestinal epithelial cell mitogenesis. J Surg Res 81: 101-107
10. Grosch S, Tegeder I, Niederberger E, Brautigam L, Geisslinger G (2001) COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. FASEB J 15: 2742-2744
11. Hanif R, Pittas A, Feng Y, Koutsos MI, Qiao L, Stainano-Coico L, Shiff SI, Rigas B (1996) Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol 26: 237-245
12. Heby O, Persson L (1990) Molecular genetics of polyamine synthesis in eukaryotic cells. Trends Biochem Sci 4: 153-158
13. Herschman HR (1991) Primary response genes induced by growth factors and tumor promoters. Annu Rev Biochem 60: 281-319
14. Herschman HR (1994) Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metast Rev 13: 241-256
15. Huber BE, Heilman CA, Thorgeirsson SS (1989) Poly(A+) RNA levels of growth-, differentiation- and transformation-associated genes in the progressive development of hepatocellular carcinoma in the rat. Hepatology 9: 756-762
16. Jochum W, Passegue E, Wagner EF (2001) AP-1 in mouse development and tumorigenesis. Oncogene 20: 2401-2412
17. Joki T, Heese O, Nikolas DC, Bello L, Zhang J, Kraeft SK, Seyfried NT, Abe T, Chen LB, Carroll RS, Black PM (2000) Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res 60: 4926-4931
18. Kavin M, Lin Z, Zandi E (1997) AP-1 function and regulation. Curr Opin Cell Biol 9: 240-246
19. Kawamori T, Rao CV, Seibert K, Reddy BS (1998) Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 58: 409-412
20. Kishimoto Y, Yashima K, Morisawa T, Shiota G, Kawasaki H, Hasegawa J (2002) Effects of cyclooxygenase-2 inhibitor NS-398 on APC and c-myc expression in rat colon carcinogenesis induced by azoxymethane. J Gastroenterol 37: 186-193
21. Kokoglu E, Tuter Y, Sandikci KS, Yazici Z, Ulakoglu EZ, Sonmez H, Ozyurt E (1998) Prostaglandin E2 levels in human brain tumor tissues and arachidonic acid levels in plasma membrane of human brain tumors. Cancer Lett 132: 17-21
22. Kusunoki N, Yamazaki R, Kawai S (2002) Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors. Arthritis Rheum 46: 3159-3167
23. Lui XH, Kirschenbaum A, Yao S, Lee R, Holland JF, Levine AC (2000) Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. J Urol 164: 820-825
24. Maxwell WJ, Kelleher D, Keating JJ, Hogan FP, Bloomfield FJ, MacDonald GS, Keeling PW (1990) Enhanced secretion of prostaglandin E2 by tissue-fixed macrophages in colonic carcinoma. Digestion 47: 160-166
25. Ostrowski J, Woszczyñski M, Kowalczyk P, Wocial T, Hennig E, Trzeciak L, Janik P, Bomsztyk K (2000) Increased activity of MAP, p70S6, and p90rs kinases is associated with AP-1 activation in spontaneous liver tumors, but not in adjacent tissue in mice. Br J Cancer 82: 1041-1050
26. Pegg AE (1986) Recent advances in the biochemistry of polyamines in eukaryotes. Biochem J 234: 249-262
27. Scheinemachers DM, Everson RB (1994) Aspirin use and lung, colon and breast cancer incidence in a prospective study. Epidemiology 5: 138-146
28. Schmidt EV (1999) The role of c-myc in cellular growth control. Oncogene 18: 2988-2996
29. Sheng H, Shao J, Morrow JD, Beauchamp RD, DuBois RN (1998) Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 58: 362-366
30. Smith ML, Hawcroft G, Hull MA (2000) The effects of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action. Eur J Cancer 36: 664-674
31. Smith WL, Garavito RM, DeWitt DL (1996) Prostaglandln endoperoxide H synthase (cyclooxygenase)-1 and 2. J Biol Chem 271: 33157-33160
32. Subbaramaiah K, Telang N, Ramonetti JT, Araki R, DeVito B, Weksler BB, Dannenberg AJ (1996) Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res 56: 4424-4429
33. Szabo IL, Pai R, Soreghan B, Jones MK, Baatar D, Kawanaka H, Tarnowski AS (2001) NSAIDs inhibit the activation of egr-1 gene in microvascular endothelial cells. A key to inhibition of angiogenesis? J Physiol 95: 379-383
34. Taketo MM (1998a) Cyclooxygenase inhibitors in tumorigenesis (Part I). J Natl Cancer Inst 90: 1529-1536
35. Taketo MM (1998b) Cyclooxygenase inhibitors in tumorigenesis (Part II). J Natl Cancer Inst 90: 1609-1615
36. Tamori A, Nishiguchi S, Kuroki T, Seki S, Kobayashi K, Kinoshita H, Otani S (1994) Relationship of ornithine decarboxylase activity and histological findings in human hepatocellular carcinoma. Hepatology 20: 1179-1186
37. Taub R (1996) Transcriptional control of liver regeneration. FASEB J 10: 413-427
38. Thun MJ, Namboodiri MM, Heath CW (1991) Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325: 1593-1596
39. Tiberio L, Maier JA, Schiaffonati L (2001) Down-regulation of c-myc expression by phorbol ester protects CEM T leukaemia cells from starvation-induced apoptosis: role of ornithine decarboxylase and polyamins. Cell Death Differ 8: 967-976
40. Tice DV, Solovlev I, Polakis P (2002) Activation of the Wnt pathway interferes with SRE-driven transcription of immediate early genes. J Biol Chem 277: 6118-6123
41. Turchanowa L, Dauletbaev N, Milovic V, Stein J (2001) Nonsteroidal anti-inflammatory drugs stimulate spermidine/spermine acetyltransferase and deplete polyamine content in colon cancer cells. Eur J Clin Invest 31: 887-893
42. Uefuji K, Ichikura T, Shinomiya N, Mochizuki H (2000) Induction of apoptosis by JTE-522, a specific cyclooxygenase-2 inhibitor in human gastric cancer cell lines. Anticancer Res 20: 4279-4284
43. Vermes I, Haanen C, Richel DJ, Schaafsma MR, Kalsbeek-Batenburg E, Reutelingsperger CP (1997) Apoptosis and secondary necrosis of lymphocytes in culture. Acta Haematol 98: 8-13
44. Whittle BJR (2000) COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors. Gut 47: 320-325
45. Williams CS, Watson AJ, Sheng H, Helou R, Shao J, DuBois RN (2000) Celecoxib prevents tumor growth in vivo without toxicity to normal gut; lack of correlation between in vitro and in vivo models. Cancer Res 60: 6045-6051
46. Williams-Ashman HG, Coppoc LL, Weber G (1972) Imbalance ornithine metabolism in hepatomas of different growth rates expressed in formation of putrescine, spermidine, and spermine. Cancer Res 32: 1924-1932
47. Yamazaki R, Kusunoki N, Matsuzaki T, Hashimoto S, Kawai S (2002) Selective cyclooxygenase-2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells. FEBS Lett 531: 278-284
48. Zhang Z, DuBois RN (2001) Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor. Oncogene 20: 4450-4456
49. Zimmermann KC, Sarbia M, Weber AA, Borchard F, Gabbert HE, Schror K (1999) Cyclooxygenase-2 expression in humam esophageal carcinoma. Cancer Res 59: 198-204